DETROIT – On November 15, United States Senator Debbie Stabenow (D-MI) visited the Henry Ford Cancer Institute and toured the new Brigitte Harris Cancer Pavilion with the Greek-American doctor Steven Kalkanis.

The new cancer pavilion is a global destination site for ambulatory cancer treatment, precision medicine, clinical trials and research, and enhanced cancer support services. It was “designed to provide an exceptional care experience surrounded in compassion, convenience, innovation, and most importantly, hope,” according to a social media post by the Henry Ford Health System.

“Thank you, U.S. Senator Debbie Stabenow for your steadfast support of innovation at the Henry Ford Cancer Institute, and for touring our new Brigitte Harris Cancer Pavilion today,” Dr. Kalkanis said.

Dr. Kalkanis is Chief Executive Officer of the Henry Ford Medical Group with more than 2,000 physicians and researchers, and Chief Academic Officer and Senior Vice President of Henry Ford Health System, a $7 billion enterprise with over 33,000 employees and five acute care hospitals in southeast Michigan. Before taking over as CEO, Dr. Kalkanis served as professor and chair of the Department of Neurosurgery, and co-director of the Neuroscience Institute at Henry Ford in Detroit. He also served as the founding Medical Director of the Henry Ford Cancer Institute (HFCI), which has grown into a $1.3B enterprise with 1,425 employees treating more than 8,000 new cancer patients and over 100,000 patient visits each year across all five Henry Ford sites – one of the largest cancer centers in the country. Dr. Kalkanis and his team also spearheaded one of the country’s most comprehensive precision medicine and molecular tumor board programs for all cancer types.